Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen-Reference-Cited by-同舟云学术

Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen

Published:2020-11-09 Issue:23 Volume:133 Page:2808-2815
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Sun Li-Qin,Liu Jia-Ye,He Yun,Zhou Yang,Xu Liu-Mei,Zhang Lu-Kun,Zhao Fang,Liu Xiao-Ning,Song Ying,Cao Ting-Zhi,Tian Yi-Mei,Rao Man,Wang Hui

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference35 articles.

1. Lipid abnormalities in persons living with HIV infection;Waters;Can J Cardiol,2019

2. HIV and its relationship to insulin resistance and lipid abnormalities;Non;Transl Res,2017

3. Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different drugs associated with different lipid profiles?;Fontas;J Infect Dis,2004

4. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis;Shah;Circulation,2018

5. Time to recognize HIV infection as a major cardiovascular risk factor;Hsue;Circulation,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baicalein ameliorates lipid accumulation in HepG2 cells via the pregnane X receptor signaling pathway;Food Bioscience;2024-08

2. Interaction between antiretroviral therapy regimens and body mass index on triglyceride levels in people living with HIV: a cross-sectional and longitudinal study;Lipids in Health and Disease;2024-07-30

3. Changes in blood lipid levels and influencing factors among treatment-naïve adult male HIV/AIDS patients following BIC/FTC/TAF vs. 3TC+EFV+TDF;Chinese Medical Journal;2024-05-30

4. Efficacy and effect on lipid profiles of switching to ainuovirine-based regimen versus continuing efavirenz-based regimen in people with HIV-1: 24-week results from a real-world, retrospective, multi-center cohort study;Antimicrobial Agents and Chemotherapy;2024-04-03

5. Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas;Life;2024-03-28